SANUWAVE Health Hits 52-Week Low at $20.84 Amid Market Volatility

SANUWAVE Health, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 20.84 on March 13, 2026. This significant decline highlights the stock's performance over the past year, where it has faced challenges compared to the S&P 500, which has shown a performance of 20.12%. With a market capitalization of USD 208 million, SANUWAVE Health operates in a competitive industry characterized by innovation and rapid changes. The company's financial metrics reveal a loss-making position, as indicated by the absence of a price-to-earnings (P/E) ratio. Additionally, the stock's price-to-book ratio stands at -70.96, reflecting underlying financial complexities. The company's debt-to-equity ratio is reported at -4.76, suggesting a unique financial structure, while the return on equity is notably negative at -999,999.00%. These figures contribute to a comprehensive understanding of SANUWAVE Health's current market standing as it navigates through a challenging financial landscape.